Skip to main content
logo
Astria Therapeutics, Inc. (ATXS)
Jan 26, 2026 - ATXS was delisted (reason: acquired by BCRX)
12.58
0.00 (0.00%)
Inactive · Last trade price on Jan 22, 2026

Astria Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Cap
7185053154887043
Market Cap Growth
50.24%60.09%-35.36%594.91%63.24%-41.51%
Enterprise Value
590.19277.07164.27358.4641.42-0.9
Last Close Price
12.588.947.6814.895.3912.84

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
5.151.581.302.200.571.06

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/EBITDA Ratio
-----0.02
EV/EBIT Ratio
-----0.02
EV/FCF Ratio
-----0.03

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.020.020.000.000.000.03
Quick Ratio
10.4217.1521.3424.9924.127.03
Current Ratio
10.7817.4921.7325.1324.427.25
Return on Equity (ROE)
-44.90%-33.52%-31.40%-30.18%-239.19%-97.66%
Return on Assets (ROA)
-44.45%-37.37%-34.22%-29.88%-222.87%-83.90%
Return on Invested Capital (ROIC)
-1186.63%3380.03%2254.11%1504.16%6448.69%5038.36%
Return on Capital Employed (ROCE)
-47.77%-39.40%-35.74%-31.12%-238.68%-96.22%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Buyback Yield / Dilution
-14.24%-86.44%-106.03%-63.81%-191.81%-63.87%
Total Shareholder Return
-14.24%-86.44%-106.03%-63.81%-191.81%-63.87%
SEC Filings: 10-K · 10-Q